Item 1A. RISK FACTORS
5K characters. Original on sec.gov ·
Item 1A. RISK FACTORS
An investment in our common stock involves risks. Before making an investment decision, you should carefully
consider all the information within Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and
Results of Operations,” as well as in our condensed consolidated financial statements and the related notes
included in Part I, Item 1, “Financial Statements,” within this Quarterly Report. In addition, you should carefully
consider the risks and uncertainties described in Part I, Item 1A, “Risk Factors,” of our 2026 Annual Report, as well
as in our other public filings with the SEC. If any of the identified risks are realized, our business, results of
operations, financial condition, liquidity, and prospects could be materially and adversely affected. In that case, the
trading price of our common stock may decline, and you could lose all or part of your investment. In addition, other
risks of which we are currently unaware, or which we do not currently view to be material, could have a material
adverse effect on our business, results of operations, financial condition, liquidity, and prospects.
During the three months ended September 30, 2026, there were no material changes to the risks and uncertainties
described in Part I, Item 1A, “Risk Factors,” of our 2026 Annual Report.
| Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Unregistered Sales of Equity Securities
None.
Use of Proceeds
Not applicable.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
Our Board of Directors (Board) has approved a stock repurchase program which authorizes us to repurchase
shares of our common stock in the open market or in privately negotiated transactions, subject to market conditions,
applicable legal requirements, and other factors (collectively, the stock repurchase program). Our Board last
approved an additional authorization of $3,500,000 on May 20, 2026, to repurchase shares of our common stock
under the same conditions as our prior stock repurchase program. As of September 30, 2026, the aggregate
remaining authorization under our stock repurchase program is $4,412,139.
Our stock repurchase program does not obligate us to acquire any amount of common stock and may be
suspended at any time at our discretion.
Stock repurchase activity under our stock repurchase program during the three months ended September 30, 2026,
was as follows:
| Total Number of Shares Repurchased (1) (2) | Weighted Average Price per Share | Dollar Value of Shares Repurchased (2) (3) | Dollar Value of Shares Remaining for Repurchase (2) | |||||
| July 1 - July 31, 2026 | 1,240,372 | $102.52 | $127,167 | $4,584,249 | ||||
| August 1 - August 31, 2026 | 1,214,678 | 92.30 | 112,111 | 4,472,138 | ||||
| September 1 - September 30, 2026 | 740,773 | 81.00 | 59,999 | 4,412,139 | ||||
| Total | 3,195,823 | 93.65 | $299,277 | 4,412,139 |
(1) All share repurchases were made pursuant to our stock repurchase program in open-market transactions.
(2) May not calculate on rounded amounts.
(3) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs.
Subsequent to September 30, 2026, through October 8, 2026, we repurchased 187,375 shares of our common
stock at a weighted average price of $80.05 per share for $15,000. As of October 8, 2026, we had $4,397,139
remaining authorized for repurchases under the stock repurchase program.
Refer to the section titled “Liquidity” under Part I, Item 2, “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” and Note 10, “Stockholders’ Equity,” of our condensed consolidated financial
statements in Part I, Item 1 within this Quarterly Report, for further information on our stock repurchase program.
Previous: Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK · Next: Item 5. OTHER INFORMATION